ACE2 and COVID-19: On June 12, B38 and H4 isolated in a convalescent patient with coronavirus disease 2019 (COVID-19) were reported to block the combination between receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2), meaning that they might be involved in virus prevention Wu et al. (2020)